We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FUJISAWA HEALTHCARE CITED FOR MISLEADING PRINT AD
FUJISAWA HEALTHCARE CITED FOR MISLEADING PRINT AD
May 14, 2004
The FDA has sent a warning letter to an Illinois drugmaker for a journal advertisement that did not contain pertinent risk information about an anti-organ rejection drug; the ad also was not properly submitted for postmarketing reporting requirements.